NCT01516450View on ClinicalTrials.gov

Japanese phase1 Study of Belimumab (IV vs SC)

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

December 26, 2011

Primary Completion Date

April 11, 2012

Study Completion Date

April 11, 2012

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

GSK1550188 IV

Single IV dose of belimumab 200 mg

DRUG

GSK1550188 SC

Single SC dose of belimumab 200mg

Trial Locations (1)

130-0004

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01516450 - Japanese phase1 Study of Belimumab (IV vs SC) | Biotech Hunter | Biotech Hunter